Biogate Labs Drug R&D unit has all the expertise needed for early stage drug discovery.  Our team combines skills, experience and knowledge – gained at the highest level in the pharmaceutical industry and academia – with fresh thinking and a challenging new approach.  
Our Vision:  to be the reliable drug discovery partner for academic research institutions and pharmaceutical companies.

Our Objective: to turn basic biomedical research into candidate medicines and to more fully exploit the potential of unexplored therapeutic targets
International Cooperation

We collaborate with local and international academic and industrial partners to identify lead compounds and potential drug targets to develop improved treatments for a wide range of diseases.

Current Focus:
  • Recombinant protein/peptides drugs
  • Mono-clone antibody drugs
  • Small molecular patent medicine
  • Hit Discovery & Optimization (biophysical assays, cellular assays, screening library)
  • Computational Chemistry (compound library selection, pharmcophore searching, constructing homology models of proteins)
  • Medicinal Chemistry (DMPK)
  • Structural Biology
  • General Facilities (Varian 4000 GC/MS/MS; Bruker AVANCE III NMR and etc.)
Please contact biogate001@biogatelab.com
or info@biogatelab.com for business/research cooperation. 
TOP